Pivot Pharmaceuticals Inc. , an emerging biotechnology company engaged in the development of therapeutics to meet unmet medical needs in women's health, is pleased to announce that the Company has ...

Stay up to date on Teva Pharmaceutical Indus analyst ratings. How Are Analyst Ratings Determined? Analysts are specialists within banking and financial systems that typically report for specific ...

Analysts have provided the following ratings for Teva Pharmaceutical Indus (NYSE:TEVA) within the last quarter: These 4 analysts have an average price target of $9.5 versus the current price of ...